If you genuinely believe there's no integrity in the ASX market then why are you investing here?
- Forums
- ASX - By Stock
- DXB
- Ann: Dimerix Confirms Phase 3 FSGS Study Design With EMA
Ann: Dimerix Confirms Phase 3 FSGS Study Design With EMA, page-34
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
52.0¢ |
Change
0.045(9.47%) |
Mkt cap ! $275.1M |
Open | High | Low | Value | Volume |
47.5¢ | 52.5¢ | 47.5¢ | $1.353M | 2.687M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 190501 | 52.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
52.5¢ | 427716 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 198551 | 0.515 |
6 | 71634 | 0.510 |
6 | 121930 | 0.505 |
7 | 100498 | 0.500 |
4 | 52589 | 0.495 |
Price($) | Vol. | No. |
---|---|---|
0.520 | 20745 | 4 |
0.525 | 391925 | 11 |
0.530 | 212152 | 8 |
0.535 | 147085 | 5 |
0.540 | 159511 | 11 |
Last trade - 11.45am 16/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online